Effect of Levisticum officinale Hydroalcoholic Extract on DU-145 and PC-3 Prostate Cancer Cell Lines

AUTHORS

Saman Sargazi 1 , Ramin Saravani ORCID 2 , * , HamidReza Galavi 2 , Fatemeh Mollashahee-Kohkan 2

1 Department of Clinical Biochemistry, School of Medicine, Shahidsadoughi University of Medical Sciences, Yazd, Iran

2 Cellular and Molecular Research Center and Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

How to Cite: Sargazi S, Saravani R, Galavi H, Mollashahee-Kohkan F. Effect of Levisticum officinale Hydroalcoholic Extract on DU-145 and PC-3 Prostate Cancer Cell Lines, Gene Cell Tissue. 2017 ; 4(4):e66094. doi: 10.5812/gct.66094.

ARTICLE INFORMATION

Gene, Cell and Tissue: 4 (4); e66094
Published Online: October 31, 2017
Article Type: Research Article
Received: August 25, 2017
Revised: September 10, 2017
Accepted: October 29, 2017
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Levisticum officinale contains a variety of components used for its medicinal properties in traditional medicine. The previous studies showed that it had an anti-cancer effect on cell lines. The current study aims to evaluate the cytotoxic potential of Levisticum officinale hydroalcoholic extract (LOHE) on DU-145 and PC-3 human advanced prostate cancer cell lines. The anti-proliferative activity of LOHE was evaluated using the MTT assay. The results of MTT showed that the IC50 of DU-145 and PC-3 were 500 µg/mL and 400 µg/mL of LOHE, respectively, following 24 hours treatment. This study found that the hydroalcoholic extract of Levisticum officinale had beneficial cell death inducing effects on both the PC3 and DU145 human prostate carcinoma cell lines in time- and concentration-dependent fashion. Hence, LOHE may have remarkable potential for uses as new natural anticancer agent.

Copyright © 2017, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited

1. Background

Prostate cancer (PCa) continues to present substantial health care challenges around the world. Estimates demonstrated that it remains to be the 1st cancer diagnosis in Canadian and American males with incidence rates of 85.6 per 100000 individuals (1). PCa treatment consequences can still be challenging. Based on published reports, PCa treatment might contribute to substantial rates of not only kidney and urinary system disorders but also permanent sexual dysfunction (2). Serum or plasma measurement of prostate-specific antigen (PSA), is generally considered to be the best indicator of Pca diagnosis. PSA is a serine protease synthesized and also released by the epithelium layer of the prostate tissue (3). Although increased levels of serum PSA is a valuable marker for detecting Pca patients, diagnostic verification demands a tissue biopsy, which is an invasive procedure (4). Usual Pca treatments are prostatectomy, radiation therapy, and most recently developed androgen deprivation therapy (5). In addition, most of these treatment strategies are only implicated to the higher stages of PCa and might have undesirable side effects. Nowdays, specific targeting of Pca cells became an alternative approach, which may eventually prevent the development of life-threatening Pca.

Naturally occurring compounds with chemopreventive properties have a vast potential for their use as curative medicine, mostly in cancer therapy. Recently this natural sources compounds has shifted the cancer research fields focus toward themselves. Extensive sorts of compounds are now being used in ongoing cancer therapy investigations (6). Studies also have demonstrated the anti-tumor properties of a vast majority of medicinal herbs, which act by various mechanisms such as induction of DNA repair response (including error- free and error-prone pathways) as well as cell cycle progression/induction of apoptosis (7). Levisticum officinale is considered to be a towering perennial plant of the family Apiaceae (8) with more than 3,000 species discovered. Apiaceae family consists of several species with medicative properties frequently utilized in conventional medicine. A large number of Apiaceae family members contain bioactive compounds in their root, leaves, and other sections of the plant. This secondary metabolites are polyphenols (phenolic and flavonoid subordinates), which is hypothesized to be the main active substance of L. officinale, coumarin as a fragrant organic chemical compound (mostly furano- and pyrano- derivatives), essential fatty acids, and specific alkaloids (9).

Due to its effective spasmolytic and diuretic properties, L. officinale has gained lots of undivided attention while being used as a medicinal plant over the years (10). There is no agreement over distribution of L. officinale. However this herbal plant can be found as native to much of Europe, like southwestern Asia in Sistan and Baluchistan province of Iran (11).

In general, cancer describes as a group of non-benign diseases characterized by unnatural cell proliferatio while gaining the ability to invade alongside and even non-adjacent tissues and finally might lead to the patient death. Therefore, wide range of chemotherapeutic drugs and efficacious synthetic and natural compounds that are presently being used are cytotoxic agents that destroy malignant cells or deteriorate their growth potency. Interestingly, herbal plants with advantageous medicinal premises are recently being investigated as novel anti-tumor agents (12).

Due to the fact that there are no reported data cytotoxic activity of L. officinale in PCa, the present study was planned to investigate the cytotoxicity activity of L. officinale Hydroalcoholic extract (LOHE) towards 2 human metastatic Pca cell lines, PC3, and DU145.

2. Methods

The protocol of the present enquiry was approved by the local ethics committee of the Zahedan University of Medical Sciences and Health services.

2.1. Plant Material

L. officinale plants were collected from Sistan and Baluchistan provinces of Iran. The taxonomic verification of L. officinale was confirmed by the Biology department of the University of Sistan and Baluchistan. Then, it was dried in a dark place. With the aim to create powderized plant material, the roots of the plant were separated from aerial parts; then, the hydroalcoholic extract of the plant (under Ethanol 70%) was obtained by a Soxhlet extractor that was described previously (13), briefly. The plant was extracted from the alcoholic solvent (300 mL, 5 hours). Next, Whatman No.41 was used for filtering and the alcohol solvent was vaporized completely by use of a centrifugal evaporation. At the end, the solid extracts were thoroughly blended to provide a uniform solution, which was kept at 4°C.

2.2. Solvents and Concentrations

The selected solvent for dissolving solid extract and preparing working solution was Dimethyl sulfoxide (DMSO) (analytical grade) and the concentration of solvent in cell culture medium was less than 2%. The controls also exposed to 2% DMSO and also FBS contained fresh RPMI mediums.

2.3. In Vitro Assay for Cytotoxic Activity

Human prostate carcinoma, PC3 and DU145 cells (National Cell Bank of Iran (NCBI), Tehran, Iran) were cultured in a medium made by RPMI1640 (G. Innovative Biotech Co (INOCLON), Iran), 10% fetal bovine serum (Gibco, Thermofisher, USA), and several antibiotic including; Penicillin-Streptomycin-Amphotericin B Solution (G. Innovative Biotech Co (INOCLON), Iran). After that, the 0.22 µm microbiological filters were used to sterilize completed media and were kept at a refrigerator temperature before use. All cells were maintained in the cultural conditions, which consist of: 5% CO2 humidified atmosphere at 37°C and pH of 7.4. PC3 and DU145 cells were seeded at a concentration of 4500 cells/well in 96-well plates and incubated overnight at a cultural condition to reach 80% of confluency. The inhibitory concentration (IC50) of LOHE for both cell lines was obtained by the Tetrazolium assay (MTT) cytotoxic assay (14). For MTT assay, the cells were exposed to increasing concentrations (100, 200, 300, 400 and 500 µg/mL) of LOHE for 24, 48, and 72 hours following treatment. Then, Tetrazolium dye (5 mg/mL) was added to all treated cells of 96-well microplate and incubated at 37°C for exactly 3 hours (15, 16). The formed dissolve the formazan crystals at this stage were solved by adding 180 µl of Dimethyl sulfoxide (DMSO) to the microplate and were kept in a dark place for 20 minutes. The microtiter plate reader (Stat Fax 2100;Awareness Technology, Los Angeles, CA, USA) was used to read the absorption of formation of the color purple at 570 nm (13). All assays were repeated in at least triplicate. The inhibitory concentration (IC50) was calculated based on the following equation:

Equation 1.

IC50, which is the concentration, decreases the absorbance of treated cells by 50% with reference to the control (untreated cells). The IC50 values were obtained from the concentration-response curves and determined by cell death inducing activities of a substance resulted in 50% viability reduction at screening concentrations (17).

2.4. Statistical Analysis

Statistical analysis on all data of the current study was conducted using windows version of SPSS software (release 22, SPSS Inc., Chicago, IL, USA). The P value less than 0.05 was considered as statistically significant. Information were presented as mean ± standard deviation (SD). Non parametric version of one way ANOVA test was used to compare the viability of cells among the different groups.

3. Results

A total of 50% of maximal inhibitory effect (IC50) of LOHE has been seen in 500 and 400 µg/mL concentration on DU-145 and PC-3 cell lines, respectively, after being exposed for 24 hours. In addition, the inhibitory effect of LOHE was in concentration µg/mL and time hours dependent fashion (Figure 1A and B).

Cells were exposed with concentrations (100, 200, 300, 400, and 500 µg/mL) of extract for different times (24, 48 and 72 hours). MTT assay was used for measuring their proliferation. LOHE declined proliferation of both DU-145 (A) and PC-3 (B) prostate cancer cells in a time- and concentration-dependent fashion. Each value is presented as a mean ± SD of 3 experiments (each triplicate). *P < 0.05; **P < 0.01 compared to adjusted control groups.

Cells were exposed with concentrations (100, 200, 300, 400, and 500 µg/mL) of extract for different times (24, 48 and 72 hours). MTT assay was used for measuring their proliferation. LOHE declined proliferation of both DU-145 (A) and PC-3 (B) prostate cancer cells in a time- and concentration-dependent fashion. Each value is presented as a mean ± SD of 3 experiments (each triplicate). *P < 0.05; **P < 0.01 compared to adjusted control groups.

Figure 1. Effect of LOHE in Inhibition of Cell Growth of the Prostate Cancer DU-145 and PC-3 Cell Lines

4. Discussion

L. officinale hydro alcoholic extracts have been reported to have cell death-inducing properties in leukemia cell lines (18, 19), however, no other anti-proliferative properties have been declared. L. officinale have been proved to have principle constituents including polyacetylenes, i.e. falcarinol and falcarindiol (20). Lots of studies have reported the significance of Polyacetylenes of the falcarinol-type to have many concerning bioactivities such as antiplatelet-aggregatory (9), antimycobacterial activity (20), cytotoxic (21), anti-inflammatory (22), and also antitumor activities (23). Hence, we hypothesize that constituents, same as polyacetylenes, might have been responsible for cytotoxic activities in our study. Furthermore, other constituents of the LOHE may have impact on cytotoxicity against cancer cells.

In this study, the cytotoxic effect of LOHE on the both DU-145 and PC-3 cell lines was assessed. The findings revealed the precise growth inhibitory effect of LOHE in 500 µg/mL concentration (IC50) on DU-145 cells and 400 µg/mL concentration (IC50) on PC-3 cell line subsequent to LOHE treatment for 24 hours. Proliferation of the both DU-145 and PC-3 cell clines was remarkably inhibited in a concentration‑ and time‑dependent fashion.

A wondering but previously observed effect was that sub-toxic concentrations of LOHE triggered cell growth and proliferation. By increasing concentrations, concentration-dependent anti proliferative effects were observed. Corresponding effects have earlier been detailed for some chemotherapeutic anticancer agents including cisplatin (24, 25). At lower subtoxic concentrations, Pca cells seem to evade the stimuli via induction of proliferation, in spite of the fact that at higher concentrations, this defending mechanism is reversed by cytotoxic effects.

4.1. Conclusion

Our investigation showed that the hydroalcoholic extract L. officinale inhibits cell growth in both the PC3 and DU145 human prostate cancer cell lines. The results gathered beneficial knowledge with regard to LOHE, as a potent antineoplastic agent to reduce cell viability and proliferation. Further inquiry is recommended not only to evaluate the cytotoxic properties of LOHE on other tumor cell lines, but to also confirm the cell death inducing effects of this extract by use of molecular methods.

Acknowledgements

Footnote

References

  • 1.

    Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079-92. doi: 10.1016/j.eururo.2012.02.054. [PubMed: 22424666].

  • 2.

    Huang GJ, Sadetsky N, Penson DF. Health related quality of life for men treated for localized prostate cancer with long-term followup. J Urol. 2010;183(6):2206-12. doi: 10.1016/j.juro.2010.02.013. [PubMed: 20399462].

  • 3.

    Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 1995;154(2 Pt 1):407-13. doi: 10.1016/S0022-5347(01)67064-2. [PubMed: 7541857].

  • 4.

    Roddam AW, Duffy MJ, Hamdy FC, Ward AM, Patnick J, Price CP, et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis. Eur Urol. 2005;48(3):386-99. discussion 398-9. doi: 10.1016/j.eururo.2005.04.015. [PubMed: 15982797].

  • 5.

    Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148(6):435-48. doi: 10.7326/0003-4819-148-6-200803180-00209. [PubMed: 18252677].

  • 6.

    Denmeade SR, Isaacs JT. A history of prostate cancer treatment. Nat Rev Cancer. 2002;2(5):389-96. doi: 10.1038/nrc801. [PubMed: 12044015].

  • 7.

    Mousavi SH, Tavakkol-Afshari J, Brook A, Jafari-Anarkooli I. Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. Food Chem Toxicol. 2009;47(8):1909-13. doi: 10.1016/j.fct.2009.05.017. [PubMed: 19457443].

  • 8.

    Downie SR, Plunkett GM, Watson MF, Spalik K, Katzdownie DS, Valiejoroman CM, et al. Tribes and clades within apiaceae subfamily apioideae: The contribution of molecular data. Edinb J Bot. 2001;58(2):301-30. doi: 10.1017/s0960428601000658.

  • 9.

    Christensen LP, Brandt K. Bioactive polyacetylenes in food plants of the Apiaceae family: occurrence, bioactivity and analysis. J Pharm Biomed Anal. 2006;41(3):683-93. doi: 10.1016/j.jpba.2006.01.057. [PubMed: 16520011].

  • 10.

    Yarnell E. Botanical medicines for the urinary tract. World J Urol. 2002;20(5):285-93. doi: 10.1007/s00345-002-0293-0. [PubMed: 12522584].

  • 11.

    Gholamhoseinian A, Fallah H, Sharifi-Far F, Mirtajaddini M. The inhibitory effect of some Iranian plants extracts on the alpha glucosidase. Iranian J Basic Med Sci. 2008;11(1):1-9. doi: 10.22038/ijbms.2008.5190.

  • 12.

    Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today. 2000;5(7):294-300. doi: 10.1016/S1359-6446(00)01511-7. [PubMed: 10856912].

  • 13.

    Galavi HR, Saravani R, Shahraki A, Ashtiani M. Anti-proliferative and apoptosis inducing potential of hydroalcoholic Achillea wilhelmsii C. Koch extract on human breast adenocarcinoma cell lines MCF-7 and MDA-Mb-468. Pak J Pharm Sci. 2016;29(6 Suppl):2397-403. [PubMed: 28167484].

  • 14.

    Faezizadeh Z, Mesbah-Namin SA, Gharib A, Saravani R, Godarzi M. Evaluating the effect of lycopene on telomerase activity in the human leukemia cell line K562 [In persian]. Feyz J Kashan Univ Med Sci. 2012;16(5).

  • 15.

    Kumar SR, Priyatharshni S, Babu VN, Mangalaraj D, Viswanathan C, Kannan S, et al. Quercetin conjugated superparamagnetic magnetite nanoparticles for in-vitro analysis of breast cancer cell lines for chemotherapy applications. J Colloid Interface Sci. 2014;436:234-42. doi: 10.1016/j.jcis.2014.08.064. [PubMed: 25278361].

  • 16.

    Oh SJ, Kim O, Lee JS, Kim JA, Kim MR, Choi HS, et al. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells. Food Chem Toxicol. 2010;48(11):3227-34. doi: 10.1016/j.fct.2010.08.028. [PubMed: 20804812].

  • 17.

    Kilani S, Ben Sghaier M, Limem I, Bouhlel I, Boubaker J, Bhouri W, et al. In vitro evaluation of antibacterial, antioxidant, cytotoxic and apoptotic activities of the tubers infusion and extracts of Cyperus rotundus. Bioresour Technol. 2008;99(18):9004-8. doi: 10.1016/j.biortech.2008.04.066. [PubMed: 18538563].

  • 18.

    Bogucka-Kocka A, Smolarz HD, Kocki J. Apoptotic activities of ethanol extracts from some Apiaceae on human leukaemia cell lines. Fitoterapia. 2008;79(7-8):487-97. doi: 10.1016/j.fitote.2008.07.002. [PubMed: 18672039].

  • 19.

    Chen QC, Lee J, Jin W, Youn U, Kim H, Lee IS, et al. Cytotoxic constituents from angelicae sinensis radix. Arch Pharm Res. 2007;30(5):565-9. doi: 10.1007/BF02977650. [PubMed: 17615675].

  • 20.

    Schinkovitz A, Stavri M, Gibbons S, Bucar F. Antimycobacterial polyacetylenes from Levisticum officinale. Phytother Res. 2008;22(5):681-4. doi: 10.1002/ptr.2408. [PubMed: 18350523].

  • 21.

    Purup S, Larsen E, Christensen LP. Differential effects of falcarinol and related aliphatic C(17)-polyacetylenes on intestinal cell proliferation. J Agric Food Chem. 2009;57(18):8290-6. doi: 10.1021/jf901503a. [PubMed: 19694436].

  • 22.

    Metzger BT, Barnes DM, Reed JD. Purple carrot (Daucus carota L.) polyacetylenes decrease lipopolysaccharide-induced expression of inflammatory proteins in macrophage and endothelial cells. J Agric Food Chem. 2008;56(10):3554-60. doi: 10.1021/jf073494t. [PubMed: 18433135].

  • 23.

    Kobaek-Larsen M, Christensen LP, Vach W, Ritskes-Hoitinga J, Brandt K. Inhibitory effects of feeding with carrots or (-)-falcarinol on development of azoxymethane-induced preneoplastic lesions in the rat colon. J Agric Food Chem. 2005;53(5):1823-7. doi: 10.1021/jf048519s. [PubMed: 15740080].

  • 24.

    Tacar O, Sriamornsak P, Dass CR. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 2013;65(2):157-70. doi: 10.1111/j.2042-7158.2012.01567.x. [PubMed: 23278683].

  • 25.

    Cepeda V, Fuertes MA, Castilla J, Alonso C, Quevedo C, Perez JM. Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med Chem. 2007;7(1):3-18. doi: 10.2174/187152007779314044. [PubMed: 17266502].

  • COMMENTS

    LEAVE A COMMENT HERE: